Phase I Trial of Oral PX-866

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00726583
Recruitment Status : Completed
First Posted : August 1, 2008
Last Update Posted : May 17, 2018
Information provided by (Responsible Party):
Seattle Genetics, Inc. ( Cascadian Therapeutics Inc. )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2011
  Actual Study Completion Date : September 2011